US Imposes 100% Tariff on Imported Branded Pharmaceuticals

The Trump administration has announced a significant shift in trade policy, stating it will impose 100% tariffs on branded pharmaceutical products imported into the United States unless manufacturers agree to specific drug pricing deals or commit to domestic production. This initiative is designed to incentivize the onshoring of manufacturing and lower the costs of prescription medications for American consumers.